Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. April 2026 07:30 ET | Quelle: BridgeBio Pharma, Inc.

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic...
22. April 2026 07:30 ET | Quelle: Stock Yards Bancorp, Inc.

Stock Yards Bancorp Reports First Quarter Earnings of $36.6 Million or $1.24 Per Diluted Share

LOUISVILLE, Ky., April 22, 2026 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and...
22. April 2026 07:30 ET | Quelle: Arq, Inc.

Arq Schedules First Quarter 2026 Earnings Conference Call

GREENWOOD VILLAGE, Colo., April 22, 2026 (GLOBE NEWSWIRE) -- Arq, Inc. (NASDAQ: ARQ) (the "Company" or "Arq"), a producer of activated carbon and other environmentally efficient carbon products for...
22. April 2026 07:30 ET | Quelle: Zevra Therapeutics

Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call

BOSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare...